Related Experiment Video
Updated: May 24, 2026

Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
[Drug-induced osteoporosis]
1Université Paris-Descartes, service de rhumatologie, hôpital Cochin, AP-HP, 75014 Paris. karine.briot@cch.aphp.fr
Abstract:
Optimal care of patients at risk of osteoporosis (low bone density and/or fracture) requires the assessment of risk factors of osteoporosis and fracture (lifestyle risk factors, chronic diseases and drugs). Among drugs, prior and current use of oral corticosteroids is strongly associated with an increased risk of fractures. But other medications could be involved and should be assessed in patients at risk of fractures. There are a strong evidence for GnRH agonists and aromatase inhibitors, antiepileptic, selective serotonin reuptake inhibitors, proton pump inhibitors. Further studies are necessary to confirm bone deleterious effect of other treatments.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Drug Toxicity: Dose-Dependent Reactions
Drug Distribution: Tissue Binding
For...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Drug toxicity: Drug–Drug Interaction